![]() |
Proton Pump Inhibitor Use and Complications...
June 1, 2012 - Clinical By: Lauren Kaveski, Pharm.D. Candidate c/o 2013 – We see proton pump inhibitors (PPIs) used in many medication regimens, but it is unknown whether the majority of patients receive these medications for appropriate durations or indications. For all labeled indications, other than Zollinger-Ellison Syndrome (a rare condition characterized by damaging gastrin hypersecretion and subsequent hydrochloric… |
![]() |
FDA Challenges Pharmacists’ Right to Compound...
January 1, 2012 - Featured , In the News / Politics By: Ebey P. Soman – With clearly established roles for pharmacists, compounding is recognized and upheld as a core foundation of the pharmacy profession. It allows pharmacists to provide unique and tailored medication regimens for their patients. The U.S. Food and Drug Administration (FDA) thought otherwise when the agency sued Franck’s Lab, Inc., a Florida-based… |